Netherlands Gastric Cancer Diagnostics Market to 2032
Overview
The Netherlands Gastric Cancer Diagnostics Market is expected to reach a 13.60 USD Million by 2032 and is projected to grow at a CAGR of 8.26% from 2025 to 2032.
Revenue, 2024 (USD Million)
8.53
Forecast, 2032 (USD Million)
13.60
CAGR, 2024 - 2032
8.26%
Report Coverage
Netherlands
Netherlands Gastric Cancer Diagnostics Market 2018-2032 USD Million
Netherlands Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 8.53 USD Million
- Projected Market Size (2032): 13.60 USD Million
- CAGR (2025-2032): 8.26%
Key Findings of Netherlands Gastric Cancer Diagnostics Market
- The Netherlands Gastric Cancer Diagnostics Market was valued at 8.53 USD Million in 2024.
- The Netherlands Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 8.26% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 5.42 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 11.25% during the forecast period from 2024 to 2032.
Netherlands Gastric Cancer Diagnostics Market Scope
Netherlands Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Distribution Channel
- Retail Sales
- Direct Tender
Netherlands Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 8.53 USD Million |
| Market Value in 2032 | 13.60 USD Million |
| CAGR (2025-2032) | 8.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Netherlands, leading in terms of revenue 8.53 USD Million in 2024
- Key Country: Netherlands, leading in terms of revenue with value of 8.53 USD Million in 2024.
Segments and Scope
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 4.74 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.15 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 4.94 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.25 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 3.25 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.65 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 4.58 USD Million in the year 2024.
- Male is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.14 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 3.52 USD Million in the year 2024.
- Stool is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.12 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 2.97 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.25 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 4.59 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.42 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 3.77 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.35 % in forecast period 2025-2032.
-
Netherlands Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a revenue of 5.42 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Netherlands Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.23 % in forecast period 2025-2032.
Netherlands Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Netherlands Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Netherlands Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Netherlands Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
Netherlands Gastric Cancer Diagnostics Market was valued at USD 8.53(Revenue in USD Million) in 2020.
Netherlands Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.26% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Netherlands Gastric Cancer Diagnostics Market, holding a largest market share of 5.42 USD Million in 2024
Netherlands Gastric Cancer Diagnostics Market Scope
Netherlands Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Netherlands Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
Netherlands Gastric Cancer Diagnostics Market was valued at USD 8.53(Revenue in USD Million) in 2020.
Netherlands Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.26% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Gastric Cancer Diagnostics Market for final year is USD 13.60 (USD Million).
Netherlands Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Netherlands Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Age Group,Disease Type,Distribution Channel.
Netherlands Gastric Cancer Diagnostics Market was valued at USD 8.53(Revenue in USD Million) in 2020.
Netherlands Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.26% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Gastric Cancer Diagnostics Market for final year is USD 13.60 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.